Company intelligence / Profile preview

Aqueduct Critical Care

Bothell, Washington, United Statesgust.com ↗

Ownership: Private
Employees: ~14
Development stage: Other

Overview

Aqueduct Critical Care has developed the Smart External Drain (SED) System, an automated device for cerebrospinal fluid (CSF) drainage and intracranial pressure (ICP) monitoring. The SED System is designed to improve patient safety, increase mobility, reduce staff workload, and provide more consistent ICP management compared to traditional manual systems. The SED has received FDA 510(k) clearance for modifications and is positioned as a next-generation standard of care in neurocritical care settings.

Therapeutic areas: Neurology
Modalities: Device (specifically, automated external drainage and monitoring system for cerebrospinal fluid)
Industry: Therapeutic Medical Devices

Partnerships

AngelMD investment syndicate partnership with physician network support

Beyond the preview

Go deeper on Aqueduct Critical Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aqueduct Critical Care.

Explore the full profile